<乌鸦传媒>Broader Cancer Risk With CAR-T? AI for Physician Burnout; 'Lollipops' ID Oral Cancer News, features, and commentary about cancer-related issues Mar 22, 2024
<乌鸦传媒>EPA Bans Asbestos, a Deadly Carcinogen Still in Use Decades After Partial Ban New rule would prohibit chrysotile asbestos Mar 19, 2024
<乌鸦传媒>First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests Retrospective analysis finds similar OS, PFS whether or not patients also received chemotherapy Mar 07, 2024
<乌鸦传媒>A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu News, features, and commentary about cancer-related issues Mar 07, 2024
<乌鸦传媒>FDA OKs Amivantamab as First-Line Lung Cancer Treatment Bispecific drug lands full approval for NSCLCs with EGFR exon 20 insertion mutations Mar 04, 2024
<乌鸦传媒>Changing the Surgical Paradigm in Oligometastatic NSCLC Propensity-score matched analysis suggests survival benefit with surgery to the primary tumor Feb 23, 2024
<乌鸦传媒>Transforming Shots Into Pills; 'Tip of the Iceberg' for TILs? Food Additives Warning News, features, and commentary about cancer-related issues Feb 23, 2024
<乌鸦传媒>Another COVID Toll: Over 134,000 Undiagnosed Cancers During Height of Pandemic Diagnosis rates remained low throughout 2020, with mortality increase projected Feb 22, 2024
<乌鸦传媒>Arginine Starvation Boosts OS in Mesothelioma With frontline immunotherapy now standard, strategy could potentially find home in second-line Feb 16, 2024
<乌鸦传媒>Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC But how well will the results from China translate to Western populations? Feb 16, 2024
<乌鸦传媒>Rush to Publish? Medicare Drug Plan Lawsuit Quashed; Activity Curbs Cancer Pain News, features, and commentary about cancer-related issues Feb 16, 2024
<乌鸦传媒>Tepotinib Gains Full Approval for Metastatic NSCLC Agency converts accelerated approval for subset with MET exon 14 mutations Feb 16, 2024
<乌鸦传媒>No Relief From Drug Shortages; New Lymphedema Guideline; A 'Good' Patient No More News, features, and commentary about cancer-related issues Feb 09, 2024
<乌鸦传媒>Smokers Who Quit and Stick With It See Greatest Reduction in Cancer Risk Cessation at any age proved helpful for lowering cancer risk Feb 06, 2024
<乌鸦传媒>Patients and Doctors Push Back Against the Harsh Side Effects of Cancer Drugs "If the patients are not taking the drug, then it's not going to work" Feb 06, 2024
<乌鸦传媒>Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer News, features, and commentary about cancer-related issues Feb 02, 2024
<乌鸦传媒>Camp Lejeune Water Contamination Tied to a Range of Cancers, CDC Study Says Health risks now more firmly established, but study falls short of being definitive Feb 01, 2024
<乌鸦传媒>Pushback on Rule for Surgical Lymph Node Sampling During Lung Resection Surgeons debate the right standard for lymph node dissection in lung cancer Jan 31, 2024
<乌鸦传媒>No Cervical Cancer After HPV Vax; Brain Tumor Blood Test; Weight Loss and Cancer News, features, and commentary about cancer-related issues Jan 26, 2024
<乌鸦传媒>How Can Cancer Risk Be Cut in Communities Exposed to Toxins? Group outlines plan to bring the latest testing and treatment to medically underserved minorities Jan 25, 2024
<乌鸦传媒>EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk Findings don't tell us to stop these drugs, researcher says, but should guide clinical decisions Jan 13, 2024
<乌鸦传媒>Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA News, features, and commentary about cancer-related issues Jan 12, 2024
<乌鸦传媒>Hypofractionated Chemoradiation With Adaptive SABR Appeared Effective in NSCLC Dose of 70 Gy in 15 fractions showed favorable balance between safety and efficacy in small trial Jan 12, 2024
<乌鸦传媒>Cryobiopsy and Forceps Biopsy Go Head-to-Head for Diagnosing Lung Lesions When added to needle aspiration, one method yielded better samples for molecular testing in NSCLC Jan 09, 2024
<乌鸦传媒>Language Minimizing Adverse Events; HPV and Thyroid Cancer; Ultrasound Bras News, features, and commentary about cancer-related issues Jan 05, 2024
<乌鸦传媒>Futile Immunotherapy for Cancer Grows More Common Occurs most often at non-academic and low-volume centers Jan 04, 2024
<乌鸦传媒>Cancer Patients Face Frightening Delays in Treatment Approvals "For them to take weeks -- up to months -- to provide an authorization is ridiculous" Dec 30, 2023
<乌鸦传媒>Another CAR-T Warning; 'Sweet' Cancer Test; 'Molecular Jackhammer' Blows Up Cancer News, features, and commentary about cancer-related issues Dec 28, 2023
<乌鸦传媒>Mammo Responsibility Ups Screening; Opioids for Cancer Pain? Ignored Signs of CRC News, features, and commentary about cancer-related issues Dec 21, 2023
<乌鸦传媒>Homelessness Tied to Worse Cancer Outcomes Among Veterans However, all-cause mortality rates in lung, colon cancer lower versus other healthcare settings Dec 21, 2023
<乌鸦传媒>Andre Braugher's Cancer Dx; Malignancies Rising in Younger Adults; Negative Trials News, features, and commentary about cancer-related issues Dec 14, 2023
<乌鸦传媒>Grappling With Our Deadliest Cancer Here are essential steps to improve lung cancer screening Dec 10, 2023
<乌鸦传媒>Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug News, features, and commentary about cancer-related issues Dec 07, 2023
<乌鸦传媒>Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dish News, features, and commentary about cancer-related issues Dec 01, 2023
<乌鸦传媒>With an Old X-Ray, AI Can Detect High Risk of Lung Cancer in Never Smokers Tool could identify nonsmokers most likely to benefit from low-dose CT screening Nov 29, 2023
<乌鸦传媒>Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutations Researchers suggest the drug is a promising option for this rare subgroup Nov 22, 2023
<乌鸦传媒>Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Care News, features, and commentary about cancer-related issues Nov 17, 2023
<乌鸦传媒>FDA OKs New Option for Advanced ROS1-Positive Lung Cancer Drug achieved high response rates in TKI-naive and TKI-pretreated patients Nov 16, 2023
<乌鸦传媒>Lung Cancer Survival High at 20 Years With Screen-Detected Tumors After two decades, lung cancer-specific survival remained at 81% in I-ELCAP program Nov 07, 2023
<乌鸦传媒>Lambert-Eaton Myasthenic Syndrome Underdiagnosed Alongside SCLC in the U.S. Findings suggest patients with SCLC are not screened for LEMS, despite their association Nov 02, 2023
